Relevant bibliographies by topics / Inc Peters International

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Inc Peters International'

Author: Grafiati
Published: 4 June 2021
Last updated: 16 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Inc Peters International.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Inc Peters International"

1

Crow, John F. "Freud's Self-Analysis. By Didier Anzieu. Translated by Peter Graham. Madison, CT: International Universities Press, Inc., 1986. 618 pp." Psychoanalytic Quarterly 58, no. 2 (April 1989): 251–320. http://dx.doi.org/10.1080/21674086.1989.11927240.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schneeberger, E., G. Citera, P. Nash, J. S. Smolen, P. J. Mease, E. Soriano, C. Helling, et al. "AB0831 COMPARISON OF DIFFERENT REMISSION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM PHASE 3 TOFACITINIB STUDIES." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1720–21. http://dx.doi.org/10.1136/annrheumdis-2020-eular.948.

Full text
Abstract:
Background:An international task force has agreed that remission and low disease activity (LDA) are treatment targets for patients (pts) with PsA, and recommends the Disease Activity Index in Psoriatic Arthritis (DAPSA) and minimal disease activity (MDA) to assess disease activity states.1Tofacitinib is an oral Janus kinase inhibitor for the treatment of PsA.Objectives:In this post hoc analysis, we compared DAPSA LDA with MDA, and DAPSA remission with very low disease activity (VLDA) and DAS28-3(CRP) remission, in pts with PsA receiving tofacitinib.Methods:Data were pooled from 2 Phase 3 studies (OPAL Broaden [12 months;NCT01877668]; OPAL Beyond [6 months;NCT01882439]) for pts receiving tofacitinib 5 or 10 mg twice daily (BID) or placebo (PBO). DAPSA was determined by summing: swollen joint count (SJC66); tender/painful joint count (TJC68); Patient’s Global Assessment of Arthritis (PtGA; visual analogue scale [VAS]); pain (VAS); and CRP. Pts were classified as achieving MDA or VLDA when meeting ≥5 (MDA) or 7 (VLDA) of the following criteria: TJC68 ≤1; SJC66 ≤1; Psoriasis Activity and Severity Index ≤1 or body surface area ≤3%; pain (VAS) ≤15; PtGA (VAS) ≤20; HAQ-DI ≤0.5; tender entheseal points (using Leeds Enthesitis Index [LEI]) ≤1. A logistic regression model was used to assess demographic and baseline characteristics as predictors of a trend in DAPSA scores at Month (M)3. DAPSA LDA (≤14), MDA, DAPSA remission (DAPSA ≤4), VLDA and DAS28-3(CRP) remission (DAS28-3[CRP]<2.6) rates were compared at M1, M3 and M6 for pts receiving tofacitinib 5 mg BID and at M6 for pts receiving tofacitinib 5 or 10 mg BID. Agreement between disease activity indices at M6 was evaluated using a kappa test. The percentage of tofacitinib-treated pts who achieved MDA, VLDA and non-response was reported at M6, stratified by achievement of DAPSA LDA, remission or non-response.Results:This analysis included 709 pts: tofacitinib 5 mg BID, n=237; tofacitinib 10 mg BID, n=236; PBO, n=236. At M3, older patients treated with tofacitinib, and tofacitinib- or PBO-treated pts with higher baseline SJC66, TJC68, PtGA VAS, HAQ-DI, LEI and Pain VAS, were significantly (p<0.05) more likely to have higher DAPSA. DAPSA LDA, MDA, remission (DAPSA and DAS28-3[CRP]) and VLDA rates generally increased from M1 to M6 for patients receiving tofacitinib 5 mg BID (Figure a). At M6, most tofacitinib-treated pts who achieved MDA, and all who achieved VLDA, were also in DAPSA remission or LDA (Figure b). At least moderate agreement (defined by kappa values 0.41–0.60) was observed between DAPSA LDA and MDA, and between DAPSA remission and VLDA, with both doses of tofacitinib at M6 (Figure c).Conclusion:Remission and LDA rates generally increased over time in pts with PsA receiving tofacitinib. DAPSA LDA showed moderate agreement with MDA, and DAPSA remission showed at least moderate agreement with VLDA, confirming that DAPSA and MDA are useful measurement tools to assess disease activity in pts with PsA treated with tofacitinib.References:[1]Smolen et al. Ann Rheum Dis 2018;77:3-17.Acknowledgments:Study sponsored by Pfizer Inc. Medical writing support was provided by Sarah Piggott of CMC Connect, McCann Health Medical Communications, and funded by Pfizer Inc.Disclosure of Interests:Emilce Schneeberger: None declared, Gustavo Citera Grant/research support from: AbbVie, Amgen, Eli Lilly, Gema, Genzyme, Novartis and Pfizer Inc, Consultant of: AbbVie, Amgen, Eli Lilly, Gema, Genzyme, Novartis and Pfizer Inc, Peter Nash Grant/research support from: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Consultant of: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Speakers bureau: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Josef S. Smolen Grant/research support from: AbbVie, AstraZeneca, Celgene, Celltrion, Chugai, Eli Lilly, Gilead, ILTOO, Janssen, Novartis-Sandoz, Pfizer Inc, Samsung, Sanofi, Consultant of: AbbVie, AstraZeneca, Celgene, Celltrion, Chugai, Eli Lilly, Gilead, ILTOO, Janssen, Novartis-Sandoz, Pfizer Inc, Samsung, Sanofi, Philip J Mease Grant/research support from: Abbott, Amgen, Biogen Idec, BMS, Celgene Corporation, Eli Lilly, Novartis, Pfizer, Sun Pharmaceutical, UCB – grant/research support, Consultant of: Abbott, Amgen, Biogen Idec, BMS, Celgene Corporation, Eli Lilly, Novartis, Pfizer, Sun Pharmaceutical, UCB – consultant, Speakers bureau: Abbott, Amgen, Biogen Idec, BMS, Eli Lilly, Genentech, Janssen, Pfizer, UCB – speakers bureau, Enrique Soriano Grant/research support from: AbbVie, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer Inc, Sandoz, Consultant of: AbbVie, Eli Lilly, GlaxoSmithKline, Novartis, Pfizer Inc, Sandoz, Speakers bureau: AbbVie, Amber, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer Inc, Roche, Claudia Helling Shareholder of: Pfizer Inc, Employee of: Pfizer Inc, Annette E Szumski Shareholder of: Pfizer Inc, Employee of: Pfizer Inc, Rajiv Mundayat Shareholder of: Pfizer Inc, Employee of: Pfizer Inc, Daniela Graham Shareholder of: Pfizer Inc, Employee of: Pfizer Inc, Dario Ponce de Leon Shareholder of: Pfizer Inc, Employee of: Pfizer Inc
APA, Harvard, Vancouver, ISO, and other styles
3

Bartky, Elliot. "Is War Democracy's Sole Incapacity? - Peter T. Manicas: War and Democracy. (Cambridge: Basil Blackwell, Inc., 1989. Pp. 491. $49.95.)." Review of Politics 53, no. 3 (1991): 576–80. http://dx.doi.org/10.1017/s0034670500015400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bandy, Melissa Dallas. "Review : The International Hospitality Industry, edited by Peter Jones and Abraham Pizam, New York, NY: John Wiley & Sons, Inc., 1993, 243 pp." Hospitality Research Journal 17, no. 3 (May 1994): 131–32. http://dx.doi.org/10.1177/109634809401700311.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Torrington, Derek. "Improving leadership performance, Peter L. Wright and David S. Taylor. Prentice Hall International Inc, Hemel Hempstead, 1984. No. of pages: ix + 157. Price: £8.95." Journal of Organizational Behavior 7, no. 2 (April 1986): 159–60. http://dx.doi.org/10.1002/job.4030070212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sobel, Richard. "Images of Voting/Visions of Democracy. By Peter B. Natchez. (New York: Basic Books, Inc., 1985. Pp. xv + 287. $21.95, cloth.)." American Political Science Review 80, no. 2 (June 1986): 676–77. http://dx.doi.org/10.2307/1958307.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kortum, Philip T., and S. Camille Peres. "Posters With Fellows." Proceedings of the Human Factors and Ergonomics Society Annual Meeting 60, no. 1 (September 2016): 1838. http://dx.doi.org/10.1177/1541931213601419.

Full text
Abstract:
Posters With Fellows is an opportunity to interact with some of the best scholars the Human Factors and Ergonomics Society has to offer in a low-key, intellectual setting. Fellows will present posters describing cutting-edge research from their current work, retrospectives of important work they have conducted over their careers, and descriptions of challenging new frontiers they think need to be addressed. This is a unique opportunity for students and professionals alike to talk one on one with the thought leaders of our profession on the important research issues of our time. Participants: Thomas J. Armstrong, University of Michigan, Ann Arbor Deborah A. Boehm-Davis, George Mason University Gloria L. Calhoun, U.S. Air Force Stanley H. Caplan, Usability Associates Nancy J. Cooke, Arizona State University Kermit G. Davis, University of Cincinnati Valerie J. Gawron, MITRE Corp. Douglas J. Gillan, North Carolina State University Wayne D. Gray, Rensselaer Polytechnic Institute Joel S. Greenstein, Clemson University M. Susan Hallbeck, Mayo Clinic Peter A. Hancock, University of Central Florida Robert Hoffman, Institute for Human & Machine Cognition Edmond W. Israelski, Abbvie Brian M. Kleiner, Virginia Tech Arnold M. Lund, Amazon Lab126 Thomas B. Malone, Carlow International Inc. Kathleen L. Mosier, San Francisco State University Robert W. Proctor, Purdue University Ronald G. Shapiro Matthew B. Weinger, Vanderbilt University Christopher D. Wickens, Alion Science & Technology
APA, Harvard, Vancouver, ISO, and other styles
8

Van den Bosch, F., J. C. C. Wei, P. Nash, F. J. Blanco, D. Graham, C. Zang, E. Arthur, C. Borlenghi, B. Vlahos, and A. Deodhar. "OP0107 ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH INACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AT 24 WEEKS: RESULTS OF RE-EMBARK, AN OPEN-LABEL, PHASE IV TRIAL." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 70.1–70. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1322.

Full text
Abstract:
Background:In the RE-EMBARK trial (NCT02509026), etanercept (ETN)-treated patients with non-radiographic axial spondyloarthritis (nr-axSpA) who achieved inactive disease (defined as Ankylosing Spondylitis Disease Activity Score with C-reactive protein [ASDAS CRP] <1.3) in Period 1 (P1)1discontinued ETN for ≤40 weeks.Objectives:To assess the proportion of patients with inactive disease after P1 who experienced disease flare (ASDAS with erythrocyte sedimentation rate [ASDAS ESR] ≥2.1) within 40 weeks of ETN withdrawal and to estimate time to flare following ETN withdrawal.Methods:RE-EMBARK was a multicenter, open-label, Phase IV trial of ETN in patients with active nr-axSpA (meeting Assessment in SpondyloArthritis international Society criteria and with ASDAS CRP ≥2.1) and an inadequate response to ≥2 nonsteroidal anti-inflammatory drugs (NSAIDs) while taking a stable dose of 1 NSAID for ≥2 weeks before the first ETN dose. All patients received ETN (50 mg/week) plus NSAID for the first 24 weeks (P1). At week 24, patients with inactive disease discontinued ETN for ≤40 weeks (Period 2 [P2]). Those who experienced flare during P2 were re-treated with ETN for 12 weeks in Period 3 (P3). Kaplan-Meier (KM) analysis and Cox proportional hazard models were used to 1) estimate the probability of experiencing flare within a given time period, and 2) compare data between RE-EMBARK and the EMBARK trial (NCT01258738) of patients with nr-axSpA who met RE-EMBARK P2 entry criteria (achieved inactive disease after 24 weeks of ETN treatment) and continued treatment for a further ≤40 weeks.Results:Of the 209 patients in P1 (mean age, 33 years; women, 46%; white, 89%), 119 (57%) entered P2. The proportion of patients experiencing ≥1 flare increased from 22% (25/112) at P2 week 4 to 67% (77/115) at P2 week 40. Overall, 75% (86/115) of patients in P2 experienced flare and 50% experienced flare within 16 weeks (95% CI: 13-24 weeks, KM analysis). Conversely, data from the comparator EMBARK trial suggested that <25% of patients receiving continuous ETN treatment over 40 weeks experienced flare. Cox proportional hazard model analysis showed an 85% relative risk reduction of experiencing flare during P2 in patients with inactive disease who continued ETN treatment vs those who discontinued. By P3 end 62% (54/87) of patients re-treated with ETN re-achieved inactive disease; 50% of patients who re-achieved inactive disease in P3 did so within 5 weeks (95% CI: 4-8 weeks, KM analysis). The observed trend of clinical improvement (P1), worsening (P2), and improvement (P3) was reflected in other clinical measures (Figure) plus measures of joint damage (Spondyloarthritis Research Consortium of Canada Sacroiliac Joint magnetic resonance imaging score) and quality of life (EQ-5D visual analog scale score); mean (standard deviation) score changes from each study period baseline–end were –6.1 (11.7) [P1], +1.5 (4.4) [P2], –2.0 (8.8) [P3] and +27.7 (26.7) [P1], –26.4 (30.5) [P2], +32.1 (26.3) [P3], respectively. There were no unexpected safety signals.Conclusion:For patients with nr-axSpA who achieved inactive disease with ETN and then discontinued treatment, a quarter maintained treatment-free inactive disease for 40 weeks and 50% maintained an ASDAS ESR score of <2.1 for ≥16 weeks. Re-starting ETN allowed 62% of patients who flared to re-achieve inactive disease within 12 weeks.References:[1]Van den Bosch F, et al.Ann Rheum Dis2019;78:896-7Acknowledgments:Medical writing support was provided by Lorna Forse, PhD, of Engage Scientific Solutions and was funded by Pfizer.Disclosure of Interests:Filip van den Bosch Consultant of: AbbVie, Celgene Corporation, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB, Speakers bureau: AbbVie, Celgene Corporation, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB, James Cheng-Chung Wei Grant/research support from: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, UCB, Consultant of: AbbVie, Bristol-Myers Squibb, Celgene, Chugai, Eisai, Janssen, Novartis, Pfizer Inc, Sanofi-Aventis, UCB Pharma, Peter Nash Grant/research support from: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly and Company, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Consultant of: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Speakers bureau: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Gilead, Janssen, MSD, Novartis, Pfizer Inc, Roche, Sanofi, UCB, Francisco J. Blanco Grant/research support from: Sanofi-Aventis, Lilly, Bristol MS, Amgen, Pfizer, Abbvie, TRB Chemedica International, Glaxo SmithKline, Archigen Biotech Limited, Novartis, Nichi-iko pharmaceutical Co, Genentech, Jannsen Research & Development, UCB Biopharma, Centrexion Theurapeutics, Celgene, Roche, Regeneron Pharmaceuticals Inc, Biohope, Corbus Pharmaceutical, Tedec Meiji Pharma, Kiniksa Pharmaceuticals, Ltd, Gilead Sciences Inc, Consultant of: Lilly, Bristol MS, Pfizer, Daniela Graham Shareholder of: Pfizer Inc, Employee of: Pfizer Inc, Chuanbo Zang Shareholder of: Pfizer, Employee of: Pfizer, Edmund Arthur Shareholder of: Pfizer, Employee of: Pfizer, Cecilia Borlenghi Shareholder of: Pfizer, Employee of: Pfizer, Bonnie Vlahos Shareholder of: Pfizer, Employee of: Pfizer, Atul Deodhar Grant/research support from: AbbVie, Eli Lilly, GSK, Novartis, Pfizer, UCB, Consultant of: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myer Squibb (BMS), Eli Lilly, GSK, Janssen, Novartis, Pfizer, UCB, Speakers bureau: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myer Squibb (BMS), Eli Lilly, GSK, Janssen, Novartis, Pfizer, UCB
APA, Harvard, Vancouver, ISO, and other styles
9

Tinin, Louis W. "The problem of loss and mourning: Psychoanalytic perspectives. Edited by David R. Dietrich and Peter Shabad. Madison, Conn.: International Universities Press, Inc., 1989, 499 pages, $55.00." Journal of Traumatic Stress 4, no. 3 (July 1991): 455–56. http://dx.doi.org/10.1002/jts.2490040319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bernard, Nicolas. "Free Movement of Goods in the European Community. By Oliver Peter. [London: Sweet & Maxwell. 1996. Ixxxv + 455 pp. inc. index. ISBN 0-421-51110-9. £102]." International and Comparative Law Quarterly 46, no. 2 (April 1997): 494. http://dx.doi.org/10.1017/s0020589300060711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Inc Peters International"

1

Poirier, Freddy. "Diagnostic de Faisceau par "Laser-Wire" et Mesure Rapide du Spectre de Luminosite au Collisionneur Lineaire International." Phd thesis, 2005. http://tel.archives-ouvertes.fr/tel-00010215.

Full text
Abstract:
The International Linear Collider (ILC), a high precision electron-positron machine with centre of mass energy extending up to the TeV scale, is curently being proposed and designed. With unprecedented small beam size and high intensity the ILC aims at luminosities of the order of $10^(34)$~cm$^(-2)$s$^(-1)$. Careful monitoring of the beam parameters that affect the luminosity will be mandatory if these ambitious goals are to be achieved.

One of the key parameters is beam emittance, the optimisation of which requires beam size monitors with micron resolution.
With this aim, a non-invasive laser-wire monitor prototype was designed, installed and run at the PETRA ring. Prior to its installation, background simulations and measurements were performed to verify that they would be low enough to allow
the laser-wire programme to proceed. A lead-tungstate crystal calorimeter for the laser-wire was commissioned, including a study of temperature dependance, geometrical acceptance and energy response. The first laser-wire measurements of the PETRA positron beam size were then performed. The system, calibration and results are reported here.

At the ILC, beam energy spread and beamstrahlung effects modify the luminosity spectrum. Determination of these effects is crucial in order to extract precision physics from threshold scans. In order to provide a run-time diagnostic scheme to address this, a fast luminosity spectrum measurement technique employing forward calorimetry and statistical unfolding was devised, using the Bhabha process at low angles. The scheme is described and first results are presented.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Inc Peters International"

1

Cortazzi, Hugh, ed. Carmen Blacker. GB Folkestone: Amsterdam University Press, 2017. http://dx.doi.org/10.5117/9781898823568.

Full text
Abstract:
Carmen Blacker was an outstanding scholar of Japanese culture, known internationally for her writings on religion, myth and folklore – her most notable work being The Catalpa Bow: A Study of Shamanistic Practices in Japan. Importantly, a third of the volume comprises significant extracts from the author’s diaries covering a period of more than forty years, together with a plate section drawn from her extensive photographic archive, thus providing a rare opportunity to gain a personal insight into the author’s life and work. The volume includes a wide selection of writings from distinguished scholars such as Donald Keene and her former pupil Peter Kornicki in celebration of her work and legacy, together with various essays and papers by Carmen Blacker herself that have hitherto not been widely available. In addition to her scholarship, Carmen Blacker was also highly regarded for her work in promoting Japanese Studies at Cambridge and played a vital role in helping to re-establish The Japan Society, London, post-war.
APA, Harvard, Vancouver, ISO, and other styles
2

Prima. Official Sega Genesis: Power Tips Book, Volume 3. Rocklin, CA: Prima Publishing, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ltd, ICON Group. PETER KIEWIT SONS', INC.: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series). 2nd ed. Icon Group International, Inc., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ltd, ICON Group. PETER KIEWIT SONS', INC.: Labor Productivity Benchmarks and International Gap Analysis (Labor Productivity Series). 2nd ed. Icon Group International, Inc., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heimann, Fritz. Evolution of Transparency International. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190458331.003.0005.

Full text
Abstract:
This chapter describes the development of Transparency International (TI) through the remarkable story of the transformation of the personal idea of its founder, Peter Eigen, and its esteemed recognition as one of the world’s most influential NGOs. Peter Eigen founded TI in May 1993 after two decades at the World Bank, in response to his frustration over the refusal of the World Bank to take action against corruption. The discussion includes a description of the central ideas on which TI was founded, the initial resistance to the use of transparency in its name, and the strategic choice of a headquarters that would not be linked to the United States.
APA, Harvard, Vancouver, ISO, and other styles
6

Kymlicka, Will. Linking Self-Determination and Human Rights. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198713258.003.0028.

Full text
Abstract:
Peter Jones argues that human rights can address violations of the determination principle, but cannot address violations of the selfhood principle. In this commentary, it is argued that international human rights norms should address both violations, for two key reasons. First, these violations are continuous in their underlying ideologies and in their effects on those whose rights to self-determination are denied. Second, international law was itself complicit in creating both categories of violations, and so has a special responsibility to correct them.
APA, Harvard, Vancouver, ISO, and other styles
7

Starbuck, Peter. Peter F. Drucker’s Management by Objectives and Self-Control. Edited by Adrian Wilkinson, Steven J. Armstrong, and Michael Lounsbury. Oxford University Press, 2017. http://dx.doi.org/10.1093/oxfordhb/9780198708612.013.5.

Full text
Abstract:
This chapter considers the emergence in 1954 and the evolution of Peter F. Drucker’s Management by Objectives—MbO—into what he termed a principle of management. It sets down its purpose, which is the integration of all management functions. Recorded is the involvement and cooperation with Drucker, by the Englishman John Humble who complimented Drucker’s conceptual work by producing operational books. The rise and then the apparent fall and disappearance of MbO is challenged as evidence is provided that it has been amalgamated with Quality Management and become the Japanese evolved method of management Hoshin Kanri, which is being applied by many international businesses.
APA, Harvard, Vancouver, ISO, and other styles
8

Kotzur, Markus, and Bernhard Ehrenzeller, eds. Verfassung – Gemeinwohl – Frieden. Nomos Verlagsgesellschaft mbH & Co. KG, 2020. http://dx.doi.org/10.5771/9783748921936.

Full text
Abstract:
On 13 May 2019 Peter Häberle celebrated his 85th birthday. The present volume documents the results of a festive colloquium in Hamburg. It is a personal homage of an international circle of friends and students, which – oriented on three major research interests if the jubilant: constitution, public welfare and peace – discusses fundamental questions of the constitutional state. Facing the current challenges of liberal political orders through authoritarianism and populism, the volume´s contributions stand up resolutely for a “culture of the constitution”, oriented towards the common good, against a cult of power. Included are, amongst others, Peter Häberle´s contribution on a “Culture of Peace” and on the “Weimar Constitution”. Congratulations from all over the world reflect quintessential constitutional questions from a very individual angle. With contributions by Andreas von Arnauld, Miguel Azpitarte-Sánchez, Francisco Balaguer Callejón, Bengt Beutler, Antonio D´Atena, Peter Häberle, Markus Kotzur, Pratyush Kumar, Fulco Lanchester, Gilmar Ferreira Mendes, Lothar Michael, Jörg Paul Müller, Vasco Pereira da Silva, Paolo Ridola, Ingo Wolfgang Sarlet, Michael Stolleis, Johann Justus Vasel, Alexandre Viala
APA, Harvard, Vancouver, ISO, and other styles
9

Georg, Satzinger, and Schütze Sebastian, eds. Sankt Peter in Rom, 1506-2006: Beiträge der internationalen Tagung vom 22.-25. Februar 2006 in Bonn. München: Hirmer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Böller, Florian, Steffen Hagemann, Lukas D. Herr, and Marcus Müller, eds. Weltmacht und Demokratie. Nomos Verlagsgesellschaft mbH & Co. KG, 2021. http://dx.doi.org/10.5771/9783748922889.

Full text
Abstract:
This volume addresses the international challenges that the US faces in the post-Trump era. Will President Joe Biden succeed in restoring the traditional leadership role of the US? What are the international and domestic hurdles for Biden in advancing his foreign policy agenda? Drawing on a liberal perspective in international relations, the chapters highlight how domestic and international politics are intertwined. Societal interests, partisan polarisation, and executive–legislative relations shape the hegemon’s international role in various policy areas, such as arms control and climate and trade policy, but also regarding the country’s relationships towards friends and foes. The book brings together the expertise of scholars who specialise in the US and transatlantic relations, in celebration of Jürgen Wilzewski. With contributions by Hakan Akbulut, Johannes Artz, Florian Böller, Gordon Friedrichs, Gerlinde Groitl, Steffen Hagemann, Lukas Herr, Katja Leikert, Marcus Höreth, Gerhard Mangott, Marcus Müller, Ronja Ritthaler-Andree, Peter Rudolf, Oliver Thränert, Söhnke Schreyer, David Sirakov, Georg Wenzelburger and Reinhard Wolf.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Inc Peters International"

1

Seale, James L., Cody P. Dahl, Charles B. Moss, and Anita Regmi. "International Evidence on Cross-Price Effects of Food and Other Goods." In Festschrift in Honor of Peter Schmidt, 125–218. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4899-8008-3_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Franke, Michael. "Peter A. Hall und David Soskice." In Handelspolitik und Welthandel in der Internationalen Politischen Ökonomie, 289–301. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-28656-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shilko, Evgeny V., Valentin L. Popov, Olga S. Vasiljeva, and Georg-Peter Ostermeyer. "In Memory of Sergey G. Psakhie." In Springer Tracts in Mechanical Engineering, 1–23. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-60124-9_1.

Full text
Abstract:
AbstractThis introductory chapter is dedicated to the life and work of Sergey Grigirievich Psakhie, his outstanding contributions to the development of science and education in Russia and especially in the Tomsk region as well as to his numerous international collaborations and research interests. It further includes personal notes from some of his closest collaborators: Georg-Peter Ostermeyer, Valentin L. Popov, Lev B. Zuev and Valery V. Ruzich. The Chapter is concluded by an overview of Sergey G. Psakhie’s most significant scientific publications.
APA, Harvard, Vancouver, ISO, and other styles
4

Hung, Sik Hin, and Jennifer Yim Shui Wa. "Dharma Therapy: A Buddhist Counselling Approach to Acknowledging and Enhancing Perspectives, Attitudes and Values." In International Perspectives in Values-Based Mental Health Practice, 305–11. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47852-0_35.

Full text
Abstract:
AbstractIn the modern world, psychological problems like anxiety and depression are common phenomena in society. Dharma therapy is a Buddhist teaching-based therapeutic intervention which utilizes the Buddhist model of ending suffering to help clients to deal with psychological issues. In many cases, it has been shown to be effective. The present case study illustrates how the client, Mr. Peter Chan, who was suffering from anxiety, benefited from going through the intervention of Dharma Therapy. The article will describe what is Dharma Therapy, Mr. Chan’s psychological issues and how the seven steps of Dharma Therapy helped Mr. Chan to deal with his sufferings. Psychological tests administered before and after the therapeutic intervention showed improvement in all aspects of anxiety.
APA, Harvard, Vancouver, ISO, and other styles
5

Rittner, Christian, and Peter M. Schneider. "Speech of the Minister of Justice of Rheinland-Pfalz (Germany) Peter Caeser at the occasion of the opening of the 14th Congress of the International Society of Forensic Haemogenetics." In Advances in Forensic Haemogenetics, 1–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77324-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

McBride, David. "Interview with Peter Lejeune, Senior Associate, Security Management International, Inc." In Bioterrorism: The History of a Crisis in American Society, 29–33. Routledge, 2020. http://dx.doi.org/10.4324/9781003123682-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Magnarella, Paul J. "Fleeing to Sweden and Algeria." In Black Panther in Exile, 103–27. University Press of Florida, 2020. http://dx.doi.org/10.5744/florida/9780813066394.003.0007.

Full text
Abstract:
While on bail, prior to his appeals, Pete and Charlotte O’Neal escaped to Sweden and then to Algiers where Eldridge Cleaver accepted them into the International Section of the Black Panther Party. An American, Elaine Klein, helped Cleaver and the Black Panther Party become recognized by the Algerian government as an anti-colonial movement. Pete describes the organization and activities of the International Section, focusing on its contacts with the embassies of various communist states and non-state revolutionary groups. He explains the reasons for the split in the Party between Huey Newton and Eldridge Cleaver, the latter’s departure from the Party, and Pete’s assumption of the International Section’s leadership role. O’Neal describes the two plane hijackings to Algiers, the resulting frictions between the Panthers and the Algerian government, and the Panthers’ departure from Algeria. Pete also relates the Panthers’ experiences with some visitors, including Timothy Leary.
APA, Harvard, Vancouver, ISO, and other styles
8

"HÄRTLING, Peter." In International Who's Who in Poetry 2005, 716. Routledge, 2004. http://dx.doi.org/10.4324/9780203325803-190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"MATTHIESSEN, Peter." In International Who's Who in Poetry 2005, 1074–75. Routledge, 2004. http://dx.doi.org/10.4324/9780203325803-288.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"MORRISS, Peter." In International Who's Who in Poetry 2005, 1139. Routledge, 2004. http://dx.doi.org/10.4324/9780203325803-306.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Inc Peters International"

1

Rosenberger, G. Walter, Peter E. Klauser, George P. Binns, and Gary P. Wolf. "Using Parametric Simulation to Optimize Suspension Design." In ASME 2003 International Mechanical Engineering Congress and Exposition. ASMEDC, 2003. http://dx.doi.org/10.1115/imece2003-55257.

Full text
Abstract:
A project to design and implement suspension improvements to Amtrak’s F-40 Non-Powered Control Unit (NPCU) cars is described. The cars, built from former F-40 locomotives, had a history of poor ride quality. Rail Sciences Inc. (RSI) inspected one of the cab cars and measured its ride quality. Peter Klauser modeled the vehicle in NUCARS™ and validated the model against the test data. The vehicle response was primarily in pitch and bounce modes. To optimize the suspension, Klauser simulated vehicle response for a range of four suspension parameters: primary stiffness and damping, and secondary stiffness and damping. Nearly 2600 suspension combinations were considered. Simulation file setup and data analysis were performed automatically using parameter analysis software interacting with NUCARS™. The result was a five-dimensional response contour for each output variable, such as the engineer’s seat vertical and lateral accelerations, and car body acceleration. The most cost effective stiffness and damping parameters were selected from the response contour and translated into component specifications. RSI then provided Amtrak with new axle box springs and dampers, and re-tested the vehicle. The test result closely followed the predicted results from the simulation. Engineer’s seat vertical and cab lateral accelerations improved by 42% and 32% respectively for the worst-case conditions in the test territory.
APA, Harvard, Vancouver, ISO, and other styles
2

Rafael da Silva, Milton, Pedro Henrique Ferreira Machado, Luiz Edival de Souza, and Carlos Waldecir de Souza. "Colored Petri Net modeling of communication systems based on IEC 61850." In 2017 4th International Conference on Systems and Informatics (ICSAI). IEEE, 2017. http://dx.doi.org/10.1109/icsai.2017.8248432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sizikov, Alexander. "Epistle of Peter III of Antioch about azymes in Slavic translations." In 45th International Philological Conference (IPC 2016). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/ipc-16.2017.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Preface. The Test of Peter Kapitsa for Artificial Intelligence." In 2019 International Conference on Artificial Intelligence: Applications and Innovations (IC-AIAI). IEEE, 2019. http://dx.doi.org/10.1109/ic-aiai48757.2019.00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fang, Xianwen, Zhicai Xu, and Zhixiang Yin. "Distributed Processing Based on Timed Petri Nets." In Third International Conference on Natural Computation (ICNC 2007) Vol V. IEEE, 2007. http://dx.doi.org/10.1109/icnc.2007.335.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nakanishi, Junichiro, Atsushi Ohta, and Kohkichi Tsuji. "Modeling Grover's Algorithm with Colored Petri Net." In 2021 36th International Technical Conference on Circuits/Systems, Computers and Communications (ITC-CSCC). IEEE, 2021. http://dx.doi.org/10.1109/itc-cscc52171.2021.9501260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhi-wei, Tang, and Zong Dai. "Modeling Business Process Reengineering through Extended Petri Net." In 2008 Fourth International Conference on Natural Computation. IEEE, 2008. http://dx.doi.org/10.1109/icnc.2008.567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guo, Jun, Weiwei Zhang, Xunli Fan, and Lei Wang. "Petri nets based design for reconfigurable computing systems." In 2014 10th International Conference on Natural Computation (ICNC). IEEE, 2014. http://dx.doi.org/10.1109/icnc.2014.6975993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tao, Ze, and Changzhong Hao. "Synthesis of Petri Net Controller Based on Constraints Matrix." In 2008 Fourth International Conference on Natural Computation. IEEE, 2008. http://dx.doi.org/10.1109/icnc.2008.449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Xiaozhong, Long Wang, Ying Liu, and Yong Li. "Modeling the Krebs Cycle based on hybrid Petri net." In The 2015 11th International Conference on Natural Computation. IEEE, 2015. http://dx.doi.org/10.1109/icnc.2015.7378159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Inc Peters International' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography